Title
Effect of Lacosamide 200 mg Twice a Day (Bid) on Single Dose Warfarin 25 mg in Healthy Males
Single-center, Open-label, Randomized 2-way Crossover Study of the Effect of Lacosamide 200 mg Twice Daily on the Single-dose Pharmacokinetics and Pharmacodynamics of Warfarin (25 mg) in Healthy Male Volunteers
Phase
Phase 1Lead Sponsor
UCBStudy Type
InterventionalStatus
Completed No Results PostedIndication/Condition
Healthy VolunteersIntervention/Treatment
Lacosamide WarfarinStudy Participants
16The purpose of this study is to investigate the effect of Lacosamide 200 mg twice a day (bid) on single dose pharmacokinetics (PK) and pharmacodynamics (PD) of Warfarin (25 mg) in healthy male volunteers.
Strength: 200 mg, Form: Tablet, Frequency: Twice daily, Duration: 9 days
Strength: 5 mg, Form: Tablet, Frequency: 1 single dose in each period In total, during the two periods, each healthy volunteer will receive 2 single doses 3 weeks apart. Duration: single dose
Single dose of Warfarin on day 3 of a 7 day course of Lacosamide 200 mg BID
Inclusion Criteria: Healthy male volunteers 18-55 years of age BMI 18.0-30.0 kg/m2 and weight at least 50 kg Tympanic body temperature 35.0-37.5°C (95 and 99.5°F) inclusive Exclusion Criteria: Volunteer has participated or is participating in any other clinical studies of investigational drug or another Investigational Medicinal Product (IMP) within the last 3 months Volunteer is not healthy (eg, taking any drug treatments, excessive amount of alcohol, cigarettes or caffeine, having any medical or emotional/psychological problems, a drug/alcohol abuse, having abnormal safety parameters) Volunteer is taking Warfarin or Non Steroidal Anti-Inflammatory Drug (NSAID) Volunteer has history of suicide attempt Volunteer has history of coagulation abnormalities, occult blood in stool, gastrointestinal ulcer, surgery within 6 months